CD79b-directed Antibody–Drug Conjugates
- Name
- CD79b-directed Antibody–Drug Conjugates
- Accession Number
- DBCAT005702
- Description
Antibody-drug conjugates in which the antibody portion is directed towards CD79b.
- Drugs
Drug Drug Description Polatuzumab vedotin A CD79b antibody conjugate indicated to treat different types of large B-cell lymphoma. - Drugs & Drug Targets